Concepedia

Craig Zetterberg

CZ

Statistics

Publications

3

Citations

79

H-Index

3

Active since

2016

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Craig Zetterberg is an author at Vertex Pharmaceuticals (United States) specializing in pharmacokinetics, pharmacology, and hepatic bioavailability.

Publications per year

2016–2020

3

Publications

3

VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions

Craig Zetterberg, François Maltais, L. A. Laitinen et al. · Drug Metabolism and Disposition · 2016 · 40 citations

, , +17

Automation of plasma protein binding assay using rapid equilibrium dialysis device and Tecan workstation

Zhengqi Ye, Craig Zetterberg, Hong Gao · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 27 citations

, , +10

Evaluation of the Utility of PXB Chimeric Mice for Predicting Human Liver Partitioning of Hepatic Organic Anion-Transporting Polypeptide Transporter Substrates

Bo Feng, Rachel Pemberton, Wojciech Dworakowski et al. · Drug Metabolism and Disposition · 2020 · 12 citations · Full text

, , +17

1–3 of 3